{"id":13838,"date":"2017-07-22T10:05:49","date_gmt":"2017-07-22T08:05:49","guid":{"rendered":"http:\/\/miunidad.eu\/porib.com\/?p=13838"},"modified":"2021-07-22T10:09:41","modified_gmt":"2021-07-22T08:09:41","slug":"casado-lf-hernandez-ja-jarque-i-echave-m-casado-ma-castro-a","status":"publish","type":"post","link":"https:\/\/porib.com\/en\/casado-lf-hernandez-ja-jarque-i-echave-m-casado-ma-castro-a\/","title":{"rendered":"Casado LF, Hernandez JA, Jarque I, Echave M, Casado MA, Castro A"},"content":{"rendered":"<div class=\"miniatura_foto\"><img loading=\"lazy\" decoding=\"async\" class=\"size-full wp-image-13839 alignleft\" src=\"https:\/\/porib.com\/wp-content\/uploads\/2021\/07\/European-Journal-of-Haematology.jpg\" alt=\"\" width=\"90\" height=\"120\" \/><\/div>\n<p style=\"text-align: justify;\"><strong>Casado LF, Hernandez JA, Jarque I, Echave M, Casado MA, Castro A<\/strong><\/p>\n<p>&nbsp;<\/p>\n<p>&nbsp;<\/p>\n<h6 style=\"text-align: justify;\">Cost-utility analysis of idelalisib in combination with rituximab in relapsed or refractory chronic lymphocytic leukaemia<\/h6>\n<h6 style=\"text-align: justify;\"><strong>Eur J Haematol. 2018;100:264\u2013272<\/strong><\/h6>\n<div class=\"col80p\">\n<p style=\"text-align: justify;\"><a href=\"https:\/\/bmcwomenshealth.biomedcentral.com\/articles\/10.1186\/s12905-021-01310-8\" target=\"_blank\" rel=\"noopener\">M\u00c1S INFORMACI\u00d3N<\/a><\/p>\n<\/div>\n","protected":false},"excerpt":{"rendered":"<p>Casado LF, Hernandez JA, Jarque I, Echave M, Casado MA, Castro A &nbsp; &nbsp; Cost-utility analysis of idelalisib in combination with rituximab in relapsed or refractory chronic lymphocytic leukaemia Eur J Haematol. 2018;100:264\u2013272 M\u00c1S INFORMACI\u00d3N<\/p>\n","protected":false},"author":4,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"quote","meta":{"footnotes":""},"categories":[116,933,330],"tags":[],"class_list":["post-13838","post","type-post","status-publish","format-quote","hentry","category-ace-acu-tipo-de-proyecto","category-hematologia-oncohematologia","category-european-journal-of-haematology","post_format-post-format-quote"],"translation":{"provider":"WPGlobus","version":"2.10.3","language":"en","enabled_languages":["es","en"],"languages":{"es":{"title":true,"content":true,"excerpt":false},"en":{"title":false,"content":false,"excerpt":false}}},"_links":{"self":[{"href":"https:\/\/porib.com\/en\/wp-json\/wp\/v2\/posts\/13838"}],"collection":[{"href":"https:\/\/porib.com\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/porib.com\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/porib.com\/en\/wp-json\/wp\/v2\/users\/4"}],"replies":[{"embeddable":true,"href":"https:\/\/porib.com\/en\/wp-json\/wp\/v2\/comments?post=13838"}],"version-history":[{"count":1,"href":"https:\/\/porib.com\/en\/wp-json\/wp\/v2\/posts\/13838\/revisions"}],"predecessor-version":[{"id":13840,"href":"https:\/\/porib.com\/en\/wp-json\/wp\/v2\/posts\/13838\/revisions\/13840"}],"wp:attachment":[{"href":"https:\/\/porib.com\/en\/wp-json\/wp\/v2\/media?parent=13838"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/porib.com\/en\/wp-json\/wp\/v2\/categories?post=13838"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/porib.com\/en\/wp-json\/wp\/v2\/tags?post=13838"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}